Molecular Mechanism of Lncrnas in Regulation of Breast Cancer Metastasis; a Comprehensive Review Publisher



Ahmadi S¹ ; Yazdi F² ; Khastar S³ ; Kaur I^{4, 5} ; Ahmed MH⁶ ; Kumar A^{7, 8} ; Rathore G⁹ ; Kaur P¹⁰ ; Shahsavan M¹¹ ; Dehghanighorbi M¹² ; Akhavansigari R^{13, 14} Show Affiliations
Source: Cell Biochemistry and Biophysics Published:2025

Abstract

Although the number of breast cancer deaths has decreased, and there have been developments in targeted therapies and combination treatments for the management of metastatic illness, metastatic breast cancer is still the second most common cause of cancer-related deaths in U.S. women. Numerous phases and a vast number of proteins and signaling molecules are involved in the invasion-metastasis cascade. The tumor cells penetrate and enter the blood or lymphatic vessels, and travel to distant organs via the lymphatic or blood vessels. Tumor cells enter cell cycle arrest, adhere to capillary beds in the target organ, and then disseminate throughout the organ’s parenchyma, proliferating and enhancing angiogenesis. Each of these processes is regulated by changes in the expression of different genes, in which lncRNAs play a role in this regulation. Transcripts that are longer than 200 nucleotides and do not translate into proteins are called RNAs. LncRNA molecules, whose function depends on their unique molecular structure, play significant roles in controlling the expression of genes at various epigenetic levels, transcription, and so on. LncRNAs have essential functions in regulating the expression of genes linked to cell development in healthy and pathological processes, specialization, programmed cell death, cell division, invasion, DNA damage, and spread to other parts of the body. A number of cancer types have been shown to exhibit aberrant expression of lncRNAs. In this review, we describe the general characteristics, potential molecular mechanisms and targeted therapy of lncRNAs and discuss the emerging functions of lncRNAs in breast cancer. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.